缺血/再灌注损伤对大鼠心肌内源性可溶性糖基化终末产物受体分泌的影响

doi:10.3969/j.issn.1006-7795.2011.05.011

首都医科大学学报 ›› 2011, Vol. 32 ›› Issue (5): 640-644.doi: 10.3969/j.issn.1006-7795.2011.05.011

缺血/再灌注损伤对大鼠心肌内源性可溶性糖基化终末产物受体分泌的影响

董洪武^1,2, 郭彩霞¹, 杜凤和¹, 王红霞³, 曾翔俊³, 张立克³, 田俊萍¹

1. 首都医科大学附属北京天坛医院心内科,北京 100050;2. 首都医科大学教学医院北京石景山医院心内科,北京 100043;3. 首都医科大学基础医学院病理生理教研室,北京 100069

收稿日期:2011-04-08 修回日期:1900-01-01 出版日期:2011-10-21 发布日期:2011-10-21
通讯作者: 郭彩霞

Effects of myocardial ischemia/reperfusion injury on the level of endogenous soluble receptor for advanced glycation end-products(sRAGE)

DONG Hong-wu^1,2, GUO Cai-xia¹, DU Feng-he¹, WANG Hong-xia³, ZENG Xiang-jun³, ZHANG Li-ke³, TIAN Jun-ping¹

1. Department of Cardiology Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China;2. Department of Cardiology Medicine, Beijing Shijingshan Hospital, Capital Medical University, Beijing 100043, China;3. Department of Pathophysiology, School of Basic Medical Science, Capital Medical University, Beijing 100069, China

Received:2011-04-08 Revised:1900-01-01 Online:2011-10-21 Published:2011-10-21

摘要/Abstract

摘要： 目的观察在体大鼠心肌缺血/再灌注(ischemia/reperfusion,I/R)及离体培养心肌细胞单纯缺氧(hypoxia,H)或缺氧/复氧(hypoxia/reoxygenation,H/R)损伤时,血浆或培养基中可溶性糖基化终末产物受体(soluble receptor for advanced glycation end-products,sRAGE)含量的变化,了解缺血/再灌注对内源性sRAGE的影响。方法采取结扎冠状动脉左前降支的方法复制在体大鼠心肌缺血/再灌注损伤模型,分别测定缺血前10 min(BI-10)、缺血45 min时(I-45)、再灌注60 min时(R-60)、再灌注120 min时(R-120)和再灌注180 min时(R-180)的左室功能指标,包括心率(heart rate,HR)、左室收缩末压(left ventricular end systolic pressure,LVESP)、左室内压最大上升/下降速率(the maximum rate change of left ventricular pressure,±LVdp/dt_max);采用TTC染色法测定心肌梗死范围;采用酶联试剂盒测定血浆sRAGE浓度。培养乳鼠心肌细胞,复制缺氧/复氧损伤(H/R)模型,测定培养基sRAGE浓度和应用比色法测定乳酸脱氢酶(lactate dehydrogenase,LDH)活力。结果与假手术(sham)组相比较,I/R组I-45、R-60、R-120、R-180各时间点的HR、LVESP、±LVdp/dt_max均降低;在I/R组内,与BI-10相比,I-45、R-60、R-120、R-180各时点的sRAGE含量均降低。与control组相比,离体心肌细胞H(H/R)组的sRAGE含量差异无统计学意义。结论 I/R损伤血浆sRAGE含量降低,这可能与心肌缺血/再灌注损伤有关;而内源性sRAGE改变可能不是心肌细胞源性的。

关键词: 可溶性糖基化终末产物受体, 缺血/再灌注损伤, 心肌

Abstract: Objective We evaluated the plasma levels of soluble receptor for advanced glycation end-products(sRAGE) of the cardiomyocytes in vivo undergoing ischemia/reperfusion(I/R) injury and the medium levels of sRAGE of cardiomyocytes in vitro undergoing hypoxia(H) or hypoxia followed by reoxygenation(H/R). Methods The rat model of myocardial I/R injury was induced by ligation of anterior descending coronary artery. All SD rats were randomly divided into two groups as follows: I/R group and sham group. The changes of heart rate(HR), left ventricular end-systolic pressure(LVESP) and the maximum rate change of left ventricular pressure(±LVdp/dt_max) in the different time points(10 minutes before ischemia, the end of 45 minutes' ischemia, the end of 60 minutes' reperfusion, the end of 120 minutes' reperfusion and the end of 180 minutes' reperfusion, for short BI-10, I-45, R-60, R-120, R-180) were observed and analyzed. Infarction size was measured by tri-phenyltetrazolium chloride(TTC) staining. The levels of sRAGE were determined by enzyme linked immunoabsorbent assay. The isolated cardiomyocytes were randomly divided into two groups as follows: H or H/R groups and control groups. Lactate dehydrogenase(LDH) release was determined by an enzyme activity assay kit(Nanjing Institute of Jiancheng Bioengineering, Nanjing, China). Results In the period of ischemia and reperfusion(I-45, R-60, R-120, R-180), the left ventricular function(HR, LVESP,±LVdp/dt_max) in I/R group decreased compared with control group. Within I/R group, the left ventricular function and the levels of sRAGE in the different time points(I-45, R-60, R-120, R-180) were decreased as compared with BI-10. There is no statistical differences in the sRAGE levels between H or H/R groups and control groups. Conclusion Our findings indicate that the levels of sRAGE were reduced after I/R injury and suggest that the molecules of sRAGE were involved in the pathophysiological of myocardial I/R injury.

Key words: soluble receptor for advanced glycation end-products, ischemia/reperfusion injury, myocardium

中图分类号:

R 363

董洪武;郭彩霞;杜凤和;王红霞;曾翔俊;张立克;田俊萍. 缺血/再灌注损伤对大鼠心肌内源性可溶性糖基化终末产物受体分泌的影响[J]. 首都医科大学学报, 2011, 32(5): 640-644.

DONG Hong-wu;GUO Cai-xia;DU Feng-he;WANG Hong-xia;ZENG Xiang-jun;ZHANG Li-ke;TIAN Jun-ping. Effects of myocardial ischemia/reperfusion injury on the level of endogenous soluble receptor for advanced glycation end-products(sRAGE)[J]. Journal of Capital Medical University, 2011, 32(5): 640-644.

[1]	张雨, 董志翔, 李常城, 王丽, 杨敏福. 肥厚型心肌病¹⁸F-FAPI PET/CT显像的初步探索:与心脏磁共振比较[J]. 首都医科大学学报, 2022, 43(6): 845-853.
[2]	苏文, 李虹伟, 陈晖, 李卫萍. 急性心肌梗死患者D二聚体质量浓度与远期预后的关系[J]. 首都医科大学学报, 2022, 43(2): 173-177.
[3]	苗祖霈, 张迎花, 肖克令, 司瑾, 张浩宇, 李静. 肥胖程度对急性ST段抬高型心肌梗死患者预后的影响[J]. 首都医科大学学报, 2022, 43(2): 192-198.
[4]	鲍博艺, 李卫萍. 外泌体miRNA在急性心肌梗死中的研究进展[J]. 首都医科大学学报, 2022, 43(2): 199-204.
[5]	孙昊, 郑美丽, 郭宗生, 张智勇, 李晓涛. 左心室收缩功能对经皮冠状动脉介入治疗的急性下壁ST段抬高型心肌梗死患者预后的影响[J]. 首都医科大学学报, 2022, 43(2): 305-310.
[6]	隗歆, 刘丹, 武烨, 吕坤译, 申言, 刘慧荣. 丝氨酸蛋白酶Omi/HtrA2表达增加促进心肌衰老的作用[J]. 首都医科大学学报, 2021, 42(5): 783-789.
[7]	王丽, 武姣彦, 杨敏福. 初诊肺腺癌患者PET/CT显像的心肌代谢特征及影响左心室心肌代谢增高的因素分析[J]. 首都医科大学学报, 2021, 42(1): 1-7.
[8]	谷珊珊, 卢洁, 陈刚. 心肌灌注显像半定量分析对不同缺血程度老年冠状动脉粥样硬化性心脏病的诊断价值[J]. 首都医科大学学报, 2021, 42(1): 26-30.
[9]	郝鹏, 冯斯婷, 甄雷, 王晓, 王春梅, 聂绍平. SYNTAX II评分对急性ST段抬高型心肌梗死患者直接PCI术后无复流的预测价值[J]. 首都医科大学学报, 2019, 40(5): 744-748.
[10]	李靖, 高敬. 二尖瓣环自动追踪技术评价心肌梗死患者左心室收缩功能[J]. 首都医科大学学报, 2019, 40(3): 379-382.
[11]	王兆佳, 武烨, 刘丹, 王美丽, 隗歆, 刘慧荣. 不同浓度β₁-肾上腺素受体自身抗体对心肌细胞存活影响的差异性[J]. 首都医科大学学报, 2019, 40(3): 402-408.
[12]	方颖, 韦华, 吴震, 宋伟, 顾承雄. 主动脉内球囊反搏辅助不停跳冠状动脉旁路移植术在缺血性心肌病治疗中的应用[J]. 首都医科大学学报, 2018, 39(6): 933-936.
[13]	吴林果, 刘丹, 武烨, 马新亮, 刘慧荣. 衰老心肌中热休克因子1的表达与线粒体损伤的关系[J]. 首都医科大学学报, 2018, 39(2): 236-242.
[14]	张琪, 陈振文. 右冠状动脉慢性闭塞合并陈旧下壁心肌梗死病人右心功能的评价[J]. 首都医科大学学报, 2017, 38(4): 609-614.
[15]	吴晴晴, 华琦, 薛淞, 张迎花, 司瑾, 李静. 白细胞计数与急性ST段抬高型心肌梗死病人直接经皮冠状动脉介入术中无复流的关系[J]. 首都医科大学学报, 2017, 38(3): 372-376.

缺血/再灌注损伤对大鼠心肌内源性可溶性糖基化终末产物受体分泌的影响

Effects of myocardial ischemia/reperfusion injury on the level of endogenous soluble receptor for advanced glycation end-products(sRAGE)

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价